191 related articles for article (PubMed ID: 16541406)
21. Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining.
Mangold E; Pagenstecher C; Friedl W; Fischer HP; Merkelbach-Bruse S; Ohlendorf M; Friedrichs N; Aretz S; Buettner R; Propping P; Mathiak M
J Pathol; 2005 Dec; 207(4):385-95. PubMed ID: 16216036
[TBL] [Abstract][Full Text] [Related]
22. Novel genomic insertion-- deletion in MLH1: possible mechanistic role for non-homologous end-joining DNA repair.
McVety S; Younan R; Li L; Gordon PH; Wong N; Foulkes WD; Chong G
Clin Genet; 2005 Sep; 68(3):234-8. PubMed ID: 16098012
[TBL] [Abstract][Full Text] [Related]
23. Frequency of rearrangements in Lynch syndrome cases associated with MSH2: characterization of a new deletion involving both EPCAM and the 5' part of MSH2.
Pérez-Cabornero L; Infante Sanz M; Velasco Sampedro E; Lastra Aras E; Acedo Becares A; Miner Pino C; Durán Domínguez M
Cancer Prev Res (Phila); 2011 Oct; 4(10):1556-62. PubMed ID: 21791569
[TBL] [Abstract][Full Text] [Related]
24. Novel and recurrent germline alterations in the MLH1 and MSH2 genes identified in hereditary nonpolyposis colorectal cancer patients in Slovakia.
Zavodna K; Bujalkova M; Krivulcik T; Alemayehu A; Skorvaga M; Marra G; Fridrichova I; Jiricny J; Bartosova Z
Neoplasma; 2006; 53(4):269-76. PubMed ID: 16830052
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques.
Nakagawa H; Hampel H; de la Chapelle A
Hum Mutat; 2003 Sep; 22(3):258. PubMed ID: 12938096
[TBL] [Abstract][Full Text] [Related]
26. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer.
Charbonnier F; Olschwang S; Wang Q; Boisson C; Martin C; Buisine MP; Puisieux A; Frebourg T
Cancer Res; 2002 Feb; 62(3):848-53. PubMed ID: 11830542
[TBL] [Abstract][Full Text] [Related]
27. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
28. Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA.
Taylor CF; Charlton RS; Burn J; Sheridan E; Taylor GR
Hum Mutat; 2003 Dec; 22(6):428-33. PubMed ID: 14635101
[TBL] [Abstract][Full Text] [Related]
29. Alu in Lynch syndrome: a danger SINE?
Hitchins MP; Burn J
Cancer Prev Res (Phila); 2011 Oct; 4(10):1527-30. PubMed ID: 21972078
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families.
Wahlberg SS; Schmeits J; Thomas G; Loda M; Garber J; Syngal S; Kolodner RD; Fox E
Cancer Res; 2002 Jun; 62(12):3485-92. PubMed ID: 12067992
[TBL] [Abstract][Full Text] [Related]
31. Novel approaches in evaluation of pathogenicity of single-base exonic germline changes involving the mismatch repair genes MLH1 and MSH2 in diagnostics of Lynch syndrome.
Gerykova-Bujalkova M; Krivulcik T; Bartosova Z
Neoplasma; 2008; 55(6):463-71. PubMed ID: 18999873
[TBL] [Abstract][Full Text] [Related]
32. Seven novel MLH1 and MSH2 germline mutations in hereditary nonpolyposis colorectal cancer.
Krüger S; Plaschke J; Pistorius S; Jeske B; Haas S; Krämer H; Hinterseher I; Bier A; Kreuz FR; Theissig F; Saeger HD; Schackert HK
Hum Mutat; 2002 Jan; 19(1):82. PubMed ID: 11754112
[TBL] [Abstract][Full Text] [Related]
33. Prediction of MLH1 and MSH2 mutations in Lynch syndrome.
Balmaña J; Stockwell DH; Steyerberg EW; Stoffel EM; Deffenbaugh AM; Reid JE; Ward B; Scholl T; Hendrickson B; Tazelaar J; Burbidge LA; Syngal S
JAMA; 2006 Sep; 296(12):1469-78. PubMed ID: 17003395
[TBL] [Abstract][Full Text] [Related]
34. Six novel heterozygous MLH1, MSH2, and MSH6 and one homozygous MLH1 germline mutations in hereditary nonpolyposis colorectal cancer.
Rey JM; Noruzinia M; Brouillet JP; Sarda P; Maudelonde T; Pujol P
Cancer Genet Cytogenet; 2004 Dec; 155(2):149-51. PubMed ID: 15571801
[TBL] [Abstract][Full Text] [Related]
35. Screening for exonic copy number mutations at MSH2 and MLH1 by MAPH.
Akrami SM; Dunlop MG; Farrington SM; Frayling IM; MacDonald F; Harvey JF; Armour JA
Fam Cancer; 2005; 4(2):145-9. PubMed ID: 15951966
[TBL] [Abstract][Full Text] [Related]
36. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas.
Ponti G; Losi L; Pedroni M; Lucci-Cordisco E; Di Gregorio C; Pellacani G; Seidenari S
J Invest Dermatol; 2006 Oct; 126(10):2302-7. PubMed ID: 16826164
[TBL] [Abstract][Full Text] [Related]
37. Optimization of experimental conditions for RNA-based sequencing of MLH1 and MSH2 genes.
Jakubowska A; Górski B; Kurzawski G; Debniak T; Hadaczek P; Cybulski C; Kladny J; Oszurek O; Scott RJ; Lubinski J
Hum Mutat; 2001; 17(1):52-60. PubMed ID: 11139242
[TBL] [Abstract][Full Text] [Related]
38. Nine novel pathogenic germline mutations in MLH1, MSH2, MSH6 and PMS2 in families with Lynch syndrome.
Rahner N; Friedrichs N; Wehner M; Steinke V; Aretz S; Friedl W; Buettner R; Mangold E; Propping P; Walldorf C
Acta Oncol; 2007; 46(6):763-9. PubMed ID: 17653898
[TBL] [Abstract][Full Text] [Related]
39. Characterization of novel, large duplications in the MSH2 gene of three unrelated Lynch syndrome patients.
Liccardo R; De Rosa M; Rossi GB; Rigler G; Izzo P; Duraturo F
Cancer Genet; 2018 Feb; 221():19-24. PubMed ID: 29405992
[TBL] [Abstract][Full Text] [Related]
40. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.
Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C
Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]